← All trials
NCT01220531
N/AExpanded Access
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2010
- Primary completion
- Dec 1, 2021
- Completion date
- Dec 1, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Duke UniversityLead sponsor
- Duke UniversityOverall official - principal investigator
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- Enzyvant Therapeutics GmbHCollaborator
- Duke UniversitySponsor investigator
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.